Novozymes growth driver finally driving some growth

Slowly but surely, the Danish biotech company's venture into biofuels is starting to show growth in sales. This solidifies what seems to be a turning point after several years of disappointment on the market, says Novozymes CEO Peder Holk Nielsen.

Danish biotech company Novozymes has struggled for years in its business for enzymes produced for second-generation biofuels. But now it seems a breakthrough is near, says CEO Peder Holk Nielsen, who presented the company's first quarter interim report Wednesday.

He points to divisions including the company's biofuels division because the formerly ailing business is now helping secure gains for the whole enzyme shop. Despite the conventional business areas such as bioethanol still driving the result, the new markets are indeed making a stir.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Ukrainian utility hit by cyberattack

Russian hackers have allegedly carried out a cyberattack against the largest privately owned utility in Ukraine, DTEK Group. The perpetrators’ goal was to destabilize, the company reports.

Further reading

Related articles

Latest News

See all jobs